Regulus Therapeutics Inc. (RGLS)
NASDAQ: RGLS · Real-Time Price · USD
1.310
+0.040 (3.15%)
At close: Feb 21, 2025, 4:00 PM
1.271
-0.039 (-3.00%)
After-hours: Feb 21, 2025, 4:41 PM EST
Regulus Therapeutics Employees
Regulus Therapeutics had 30 employees as of December 31, 2023. The number of employees did not change compared to the previous year.
Employees
30
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
n/a
Profits / Employee
-$1,387,600
Market Cap
85.81M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 440,000 |
Johnson & Johnson | 131,900 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 92,900 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 72,000 |
RGLS News
- 18 days ago - Regulus Therapeutics to Present at the Oppenheimer 35th Annual Healthcare Life Sciences Conference - PRNewsWire
- 24 days ago - Regulus Therapeutics Announces Positive Clinical and Regulatory Updates from its Autosomal Dominant Polycystic Kidney Disease (ADPKD) Program for Farabursen (RGLS8429) - PRNewsWire
- 3 months ago - Regulus Therapeutics Announces Participation at Upcoming Healthcare Investment Conferences - PRNewsWire
- 3 months ago - Regulus Therapeutics Reports Third Quarter 2024 Financial Results and Recent Updates - PRNewsWire
- 4 months ago - Regulus Therapeutics Announces Completion of Enrollment in Fourth Cohort of Phase 1b Multiple-Ascending Dose (MAD) Clinical Trial of RGLS8429 for the Treatment of Patients with Autosomal Dominant Polycystic Kidney Disease (ADPKD) - PRNewsWire
- 6 months ago - Regulus Therapeutics Announces Participation at Two Healthcare Investment Conferences - PRNewsWire
- 7 months ago - Regulus Therapeutics Reports Second Quarter 2024 Financial Results and Recent Updates - PRNewsWire
- 7 months ago - Regulus Therapeutics to Present at the Canaccord Genuity 44th Annual Growth Conference - PRNewsWire